High titers of low affinity antibodies in COVID-19 patients are associated with disease severity

J Hendriks, R Schasfoort, M Koerselman… - Frontiers in …, 2022 - frontiersin.org
Background Almost 2 years from the beginning of the coronavirus disease 2019 (COVID-19)
pandemic, there is still a lot unknown how the humoral response affects disease …

Neutralizing and binding antibody kinetics of COVID-19 patients during hospital and convalescent phases

XY Yao, W Liu, ZY Li, HL Xiong, YY Su, TD Li… - medRxiv, 2020 - medrxiv.org
Abstract Knowledge of the host immune response after natural SARS-CoV-2 infection is
essential for informing directions of vaccination and epidemiological control strategies …

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19

K Li, B Huang, M Wu, A Zhong, L Li, Y Cai… - Nature …, 2020 - nature.com
Deciphering the dynamic changes in antibodies against SARS-CoV-2 is essential for
understanding the immune response in COVID-19 patients. Here we analyze the laboratory …

Detection of anti-SARS-CoV-2-S2 IgG is more sensitive than anti-RBD IgG in identifying asymptomatic COVID-19 patients

B Liao, Z Chen, P Zheng, L Li, J Zhuo, F Li, S Li… - Frontiers in …, 2021 - frontiersin.org
Characterizing the serologic features of asymptomatic SARS-CoV-2 infection is imperative to
improve diagnostics and control of SARS-CoV-2 transmission. In this study, we evaluated …

Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection

H Wang, Y Yuan, M Xiao, L Chen, Y Zhao… - Cellular & molecular …, 2021 - nature.com
COVID-19 caused by SARS-CoV-2 infection has caused substantial morbidity and mortality
worldwide and paralyzed the international economy. Understanding the magnitude and …

Dynamic characteristic analysis of antibodies in patients with COVID-19: a 13-month study

D Shi, T Weng, J Wu, C Dai, R Luo, K Chen… - Frontiers in …, 2021 - frontiersin.org
There is a worldwide pandemic of Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection; yet our understanding remains limited on the characteristic of antibodies …

SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

R Gozalbo-Rovira, E Gimenez, V Latorre… - Journal of Clinical …, 2020 - Elsevier
Background The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic
events in COVID-19 patients has been suggested. By using several experimental …

Longitudinal profiling of antibody response in patients with COVID-19 in a tertiary care hospital in Beijing, China

X Feng, J Yin, J Zhang, Y Hu, Y Ouyang… - Frontiers in …, 2021 - frontiersin.org
The novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) caused a global pandemic of the coronavirus disease 2019 (COVID-19), which elicits a …

[HTML][HTML] Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19

JH Park, MJ Cha, H Choi, MC Kim, JW Chung… - Journal of Microbiology …, 2022 - Elsevier
Background It remains unclear whether high titers of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies aggravate clinical manifestations in patients or …

Detailed multiplex analysis of SARS-CoV-2 specific antibodies in COVID-19 disease

SF Brynjolfsson, H Sigurgrimsdottir… - Frontiers in …, 2021 - frontiersin.org
A detailed understanding of the antibody response against SARS-CoV-2 is of high
importance, especially with the emergence of novel vaccines. A multiplex-based assay …